Lifecore Biomedical
LFCR
109 hedge funds and large institutions have $289M invested in Lifecore Biomedical in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 43 reducing their positions, and 12 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
3% more capital invested
Capital invested by funds: $282M → $289M (+$7.64M)
2% less funds holding
Funds holding: 111 → 109 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
35% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$12.5M |
| 2 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$7.58M |
| 3 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$2.25M |
| 4 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$2.24M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$645K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.65M |
| 2 |
IA
Icon Advisers
Greenwood Village,
Colorado
|
-$2.57M |
| 3 |
KG
Killen Group
Berwyn,
Pennsylvania
|
-$2.02M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$1.91M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.75M |
LFCR Hedge Fund Activity: Q4 2015 in Review
109 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q4 2015, worth a combined $289M — up 2.7% from $282M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of LFCR and 10 opened new positions — a net loss of 2 holders — while 43 trimmed existing stakes and 28 added.
The largest buyer was Franklin Resources, opening a new position worth an estimated $12.5M. The largest seller was Guggenheim Capital, cutting an estimated $2.65M.
- 109 institutional investors held Lifecore Biomedical (LFCR) as of Q4 2015, down from 111 in Q3 2015.
- Funds reported $289M of Lifecore Biomedical stock for Q4 2015, up 2.7% quarter-over-quarter.
- 10 funds opened new Lifecore Biomedical positions in Q4 2015 and 12 closed out, a net change of -2 holders.
- The largest Lifecore Biomedical buyer in Q4 2015 was Franklin Resources, an estimated $12.5M added.
- The largest Lifecore Biomedical seller in Q4 2015 was Guggenheim Capital, an estimated $2.65M sold.
Based on aggregated 13F filings for Q4 2015.